HEALTH INSURANCE PLAN OF GREATER NEW YOR – Trademark Portfolio
Entity Type: 54
HEALTH INSURANCE PLAN OF GREATER NEW YOR holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VYTRA. The owner is based in NEW YORK, NY.
55 WATER STREET
NEW YORK, NY 100384982
Showing of trademarks Trademarks
Trademark Classifications
HEALTH INSURANCE PLAN OF GREATER NEW YOR's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does HEALTH INSURANCE PLAN OF GREATER NEW YOR have?
HEALTH INSURANCE PLAN OF GREATER NEW YOR has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does HEALTH INSURANCE PLAN OF GREATER NEW YOR file in?
HEALTH INSURANCE PLAN OF GREATER NEW YOR files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are HEALTH INSURANCE PLAN OF GREATER NEW YOR's most well-known trademarks?
HEALTH INSURANCE PLAN OF GREATER NEW YOR's registered trademark portfolio includes well-known marks such as VYTRA. These are among 1 currently registered trademark in the portfolio.
What is HEALTH INSURANCE PLAN OF GREATER NEW YOR's trademark registration success rate?
HEALTH INSURANCE PLAN OF GREATER NEW YOR has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.